Publications by authors named "M A Cheeseman"

Claim this Profile
N
NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth.
Jonathan Welti, Denisa Bogdan, Ines Figueiredo, Ilsa Coleman, Juan Jiménez Vacas, Matthew Cheeseman

Clin Cancer Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disrupted biographies and gendered identities: A qualitative study exploring sexuality and blood cancer.
Natalie Hammond, Andrew Chantry, Matthew Cheeseman, Alex Peng

Eur J Oncol Nurs· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of Ligand-Binding Affinity () Using Transverse Relaxation Rate () in the Ligand-Observed H NMR Experiment and Applications to Fragment-Based Drug Discovery.
Manjuan Liu, Amin Mirza, P Craig McAndrew, Arjun Thapaliya, Olivier A Pierrat, Matthew D Cheeseman

J Med Chem· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Comparative Pathology Workbench: Interactive visual analytics for biomedical data.
Michael N Wicks, Michael Glinka, Bill Hill, Derek Houghton, Mehran Sharghi, Michael Cheeseman

J Pathol Inform· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies.
A Elisa Pasqua, Swee Y Sharp, Nicola E A Chessum, Angela Hayes, Loredana Pellegrino, Matthew D Cheeseman

J Med Chem· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis